Loading…
6 companies · GEL, thousands · columns ordered by revenue
| Company | Sector | EBITDA margin · FY 2023 | Percentile | Sector n |
|---|---|---|---|---|
| Gamma+ | Oil & Gas | 21.8% | 90th pct | 145 |
| Trans Gas | Oil & Gas | 11.1% | 81st pct | 145 |
| Gamma | Oil & Gas | 5.3% | 64th pct | 145 |
| Delta Gas | (unclassified) | 0.2% | 23rd pct | 1388 |
| Invest 2023 | (unclassified) | -33.6% | 10th pct | 1388 |
| Biospero + | (unclassified) | — | no FY data | 1388 |
Percentile is within each company's own sector across the whole FY2023 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.
| Ratio — FY 2023 | Gamma+ | Gamma | Trans Gas | Delta Gas | Invest 2023 | Biospero + |
|---|---|---|---|---|---|---|
| Margins | ||||||
| Gross Margin | 42.3% | 35.2% | 34.3% | 21.3% | 58.1% | — |
| EBITDA Margin | 21.8% | 5.3% | 11.1% | 0.2% | -33.6% | — |
| EBITDAR | 1,968 | 392 | 246 | 9 | -224 | — |
| EBITDAR Margin | 22.1% | 7.2% | 11.4% | 0.8% | -33.6% | — |
| EBIT Margin | 20.8% | 2.1% | 8.6% | -5.4% | -37.2% | — |
| Net Profit Margin | 20.8% | 2.1% | 8.6% | -5.4% | 9.1% | — |
| Operating Expense % of Sales | 20.5% | 29.9% | 23.2% | 21.0% | 91.7% | — |
| Returns | ||||||
| Return on Assets (ROA) | 129.7% | 3.2% | 17.5% | -6.1% | 0.6% | — |
| Return on Equity (ROE) | 213.6% | |||||
| 3.5% |
| 18.5% |
| N/A |
| 0.6% |
| — |
| ROIC [EBIT / Invested Capital] | 294.9% | 4.4% | 22.0% | -235.0% | -2.3% | — |
| Leverage & debt balances | ||||||
| Debt-to-Assets | 21.7% | 0.3% | 0.0% | 23.1% | 0.0% | — |
| Debt-to-Equity | 0.36x | 0.00x | 0.00x | -1.60x | 0.00x | — |
| Debt-to-EBITDA | 0.16x | 0.03x | 0.00x | 95.55x | N/A | — |
| Equity-to-Assets | 60.7% | 90.3% | 94.7% | -14.4% | 99.9% | — |
| Net Debt | -237 | -609 | -158 | 164 | -42 | — |
| Cash & Equivalents | 547 | 619 | 158 | 59 | 42 | — |
| Total Debt | 310 | 10 | N/A | 223 | N/A | — |
| Liquidity & working capital | ||||||
| Current Ratio | 2.83x | 3.36x | 4.18x | 0.31x | 25.45x | — |
| Quick Ratio | 2.83x | 3.36x | 4.18x | 0.31x | 25.45x | — |
| Cash Ratio | 2.18x | 1.86x | 2.81x | 0.19x | 2.60x | — |
| Total Current Assets | 708 | 1,120 | 236 | 95 | 409 | — |
| Total Current Liabilities | 251 | 334 | 56 | 307 | 16 | — |
| Inventory | N/A | N/A | N/A | N/A | N/A | — |
| Trade Receivables | 65 | 467 | 56 | 19 | 265 | — |
| Trade Payables | 94 | 290 | 28 | 294 | 16 | — |
| Net Working Capital | 457 | 786 | 179 | -212 | 393 | — |
| Net Working Capital % of Revenue | 5.1% | 14.4% | 8.3% | -19.5% | 59.0% | — |
| Trade Working Capital | -29 | 178 | 29 | -275 | 249 | — |
| Trade Working Capital % of Revenue | -0.3% | 3.3% | 1.3% | -25.2% | 37.4% | — |
| Change in Trade Working Capital | N/A | N/A | N/A | N/A | N/A | — |
| Turnover & efficiency | ||||||
| Inventory Turnover | N/A | N/A | N/A | N/A | N/A | — |
| Days Inventory Outstanding (DIO) | N/A | N/A | N/A | N/A | N/A | — |
| Receivables Turnover | 137.78x | 11.66x | 38.41x | 57.69x | 2.51x | — |
| Days Sales Outstanding (DSO) | 2.6 | 31.3 | 9.5 | 6.3 | 145.4 | — |
| Payables Turnover | 54.65x | 12.19x | 51.59x | 2.92x | 17.38x | — |
| Days Payable Outstanding (DPO) | 6.7 | 30.0 | 7.1 | 124.9 | 21.0 | — |
| Cash Conversion Cycle | -4.0 days | 1.4 days | 2.4 days | -118.6 days | 124.4 days | — |
| Asset Turnover | 6.24x | 1.53x | 2.04x | 1.13x | 0.06x | — |
| Cash flow & dividends | ||||||
| Operating Cash Flow | -197 | 434 | 110 | -117 | N/A | — |
| Free Cash Flow (OCF − Capex proxy) | -197 | 434 | 110 | -117 | N/A | — |
| Cash Conversion (OCF / EBITDA) | -10.2% | 150.1% | 45.9% | -5002.1% | N/A | — |
| Dividends Declared | N/A | N/A | N/A | N/A | N/A | — |
| Dividend Payout Ratio | N/A | N/A | N/A | N/A | N/A | — |